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Objective: Effect of 2 types of dialysate on hemodynamic stability &
efﬁcacy of erythropoitin was evaluated in 30 patients of CKD on
maintenance dialysis.
Methods: Thirty adult patients (15 patients in group A using
acetate containing bicarbonate dialysate and 15 in group B using
citrate containing bicarbonate dialysate) of end stage renal disease
(ESRD) undergoing twiceweekly hemodialysiswere included in the
study and were administered Erythropoietin (rHuePo) 6000 I.U.
subcutaneously following each session of dialysis and injectable
Iron 100 mg once weekly. Hemodynic stability was monitored
during dialysis and hematological parameters were recorded at
baseline & then every month.
Results: The use of citrate rather than acetate as an acidiﬁer in
bicarbonate haemodialysis reduced the symptoms during dialysis
like vomiting, chills, headache, shortness of breath, hypocapnia
with improved correction of acidosis. Hemodynamic stability
(decreased intradialytic ﬂuctuations in blood pressure was higher
in the citrate schedule. Moreover, patients who used to develop
intradialytic hypertension before inclusion experienced a larger
reduction in blood pressure. The need for intervention by the
medical staff was slightly less in citrate containing group. The rise
in hemoglobin and hematocrit in both the groups was statistically
signiﬁcant ( p < 0.0001). ESR fell signiﬁcantly ( p < 0.0001) in group B
after 3 months. Baseline KT/V was signiﬁcantly higher in group B
as compared to group A ( p < 0.01). There was steady and gradual
decline in blood urea, serum creatinine, serumuric acid and serum
phosphate in group B.
Conclusion: Citrate containing bicarbonate dialysate has signiﬁ-
cant effect in reducing inﬂammatory parameter & in improving
hemoglobin and achieved better hemodynamic stability during
dialysis.
Assessment of short term effects of
sildenafil therapy in patients with
secondary pulmonary hypertension
P. Dwivedi *, V.S. Narain, R.K. Saran, S.K. Dwivedi,
R. Sethi, S. Chandra, A. Pradhan, G.K. Chaudhary,
P.K. Vishwakarma
Department of Cardiology, King Georg's Medical University, Lucknow
226003, UP, India
Background: It is well proven that sildenaﬁl improves pulmonary
hemodynamics and exercise capacity in patients with primary
pulmonary hypertension. However, the drug armamentarium
for secondary pulmonary hypertension is limited. Sildenaﬁl may
also be helpful in this subgroup. Certain studies have shown
promising results but none of the magnitude to promulgate new
recommendations.
Methods: In this double-blind, placebo-controlled study, we ran-
domly assigned 106 patients with symptomatic secondary PAH
(idiopathic DCMP, Heart failure with preserved EF, COPD, and other
lung parenchymal disease, valvular heart disease) to placebo or
sildenaﬁl (53 in each group). Sildenaﬁl was given orally 25 mg TID
for 6 weeks. The primary end point was the change from baseline
to week 6 in the distance walked in 6 minutes. We also assessed
clinical improvement (improvement in 6 minute walk test, and
NYHA functional class, change in Borg dyspnoea index) and
change in hemodynamic parameters (PASP, LVEF).
Results: Of the 106 patients, included secondary PAH was due to
COPD in 21 (19.8%), Valvular heart disease in 53 (50%), Heart failure
with preserved EF in 16 (15%), idiopathic DCMP in 11 (10.2%) and
other lung parenchymal diseases in 5 (5%). The mean increase in
the distance walked after 6 weeks of therapy was 54 m in sildenaﬁl
group and 13 m in placebo group p = 0.04. In the sildenaﬁl group
signiﬁcantly greater number of patients improved by at least one
functional class (23% vs 11%, p = 0.003). The mean NYHA class at 6
weeks was 2.0  0.2 in the sildenaﬁl group versus 2.8  0.4 in the
placebo group, p = 0.02. The mean PASP signiﬁcantly decreased in
the sildenaﬁl group at 6 weeks (48  6 mmHg), compared to pla-
cebo (58  6 mmHg), p = 0.02. LVEF was higher in the sildenaﬁl
group, 60  10% versus 55  10% in the placebo group, but did
not reach statistically signiﬁcant difference.
Conclusion: Sildenaﬁl improves exercise capacity, functional class,
and hemodynamics in patients with PAH. PDE-5 inhibition may
represent an important therapy for patients with secondary PAH if,
the beneﬁts observed in our study are conﬁrmed in larger clinical
trials.
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Background: Chemoport is a central venous infusion system com-
monly used in cancer patients for chemotherapy and parenteral
nutrition. Detachmentwith embolization of chemoport catheter to
the heart is a rare and serious complication and warrants immedi-
ate retrieval by surgery or percutaneous approach.
Method: A 50-year-old lady suffering from left breast cancer had a
chemoport implanted in right subclavian vein. After two sessions
of chemotherapy the chemoport stopped functioning and got
infected. Chest radiograph revealed the distal portion of the cathe-
ter had detached and the catheter fragment had embolized to the
right atrium. Portal segment of the infected chemoport was
removed surgically. Detached catheter fragment in right atrium
was retrieved by inserting 12 French (F) sheath into femoral vein.
As both ends of catheter fragments were not free to use the loop
snare technique, a pigtail catheter was looped around the chemo-
port catheter and pulled down into IVC. It was planned to remove
the catheter fragment using endomyocardial biopsy forceps, how-
ever the biopsy forceps could not be negotiated into IVC and 6F
armoured sheath was used within 12F sheath for extra support.
Biopsy forcepswas introduced into the lumen of proximal tip of the
catheter and was brought down into the 12F sheath and subse-
quently retrieved with femoral sheath. The procedure was uncom-
plicated and patient got discharged the next day.
Conclusion: Percutaneous retrieval of a dislocated chemoport
catheter is a relatively safe, easy and effective technique without
the need for special devices, general anesthesia and/or surgical
intervention. Novel technique was used in our case involving
pigtail catheter with biopsy forceps supported by armoured sheath
for successful retrieval.
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